P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan et al., Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14(5), 301–316 (2018). https://doi.org/10.1038/nrendo.2018.18.
J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi et al., Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24(12), 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028.
Article PubMed PubMed Central Google Scholar
F. Magri, L. Chiovato, L. Croce, M. Rotondi, Thyroid hormone therapy for subclinical hypothyroidism. Endocrine 66(1), 27–34 (2019). https://doi.org/10.1007/s12020-019-02039-z.
Article CAS PubMed Google Scholar
L.H. Duntas, Seven decades of levothyroxine: a comprehensive profile. Adv. Ther. 36(Suppl 2), 27–29 (2019). https://doi.org/10.1007/s12325-019-01081-7.
Article PubMed PubMed Central Google Scholar
P. Miccoli, G. Materazzi, L. Rossi, Levothyroxine therapy in thyrodectomized patients. Front. Endocrinol. (Lausanne) 11, 626268 (2020). https://doi.org/10.3389/fendo.2020.626268.
P. Trimboli, N. Ossola, A. Torre, F. Mongelli, M. Quarenghi, C. Camponovo et al., The performance of levothyroxine tablet is impaired by bariatric surgery. Endocrine 80(3), 563–569 (2023). https://doi.org/10.1007/s12020-022-03289-0.
Article CAS PubMed Google Scholar
C. Virili, P. Trimboli, F. Romanelli, M. Centanni, Liquid and softgel levothyroxine use in clinical practice: state of the art. Endocrine 54(1), 3–14 (2016). https://doi.org/10.1007/s12020-016-1035-1.
Article CAS PubMed Google Scholar
C. Virili, L. Giovanella, P. Fallahi, A. Antonelli, M.G. Santaguida, M. Centanni et al., Levothyroxine therapy: changes of TSH Levels by switching patients from tablet to liquid formulation. A systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 9, 10 (2018). https://doi.org/10.3389/fendo.2018.00010.
C. Virili, P. Trimboli, M. Centanni, Novel thyroxine formulations: a further step toward precision medicine. Endocrine 66(1), 87–94 (2019). https://doi.org/10.1007/s12020-019-02049-x.
Article CAS PubMed Google Scholar
R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J. Clin. Endocrinol. Metab. 99(12), 4481–4486 (2014). https://doi.org/10.1210/jc.2014-2684.
Article CAS PubMed Google Scholar
S. Benvenga, F. Di Bari, R. Vita, Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Endocrine 56(1), 138–145 (2017). https://doi.org/10.1007/s12020-017-1244-2.
Article CAS PubMed Google Scholar
C. Cappelli, I. Pirola, L. Daffini, A. Formenti, C. Iacobello, A. Cristiano et al., A double-blind placebo-controlled trial of liquid thyroxine ingested at breakfast: results of the TICO study. Thyroid 26(2), 197–202 (2016). https://doi.org/10.1089/thy.2015.0422.
Article CAS PubMed Google Scholar
M. Giusti, L. Mortara, N. Machello, E. Monti, G. Pera, M. Marenzana, Utility of a liquid formulation of levo-thyroxine in differentiated thyroid cancer patients. Drug. Res. (Stuttg.) 65(6), 332–336 (2015). https://doi.org/10.1055/s-0034-1384535.
Article CAS PubMed Google Scholar
C.P. Lombardi, R. Bocale, A. Barini, A. D’Amore, M. Boscherini, R. Bellantone, Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients. Endocrine 55(1), 51–59 (2017). https://doi.org/10.1007/s12020-016-1003-9.
Article CAS PubMed Google Scholar
C. Cappelli, I. Pirola, E. Gandossi, C. Casella, D. Lombardi, B. Agosti et al., TSH variability of patients affected by differentiated thyroid cancer treated with levothyroxine liquid solution or tablet form. Int. J. Endocrinol. 2017, 7053959 (2017). https://doi.org/10.1155/2017/7053959.
Article CAS PubMed PubMed Central Google Scholar
V. Di Donna, R.M. Paragliola, C. de Waure, G. Papi, A. Pontecorvi, S.M. Corsello, Is levothyroxine requirement the same for tablet and soft gel formulations?. Endocrine 59(2), 458–460 (2018). https://doi.org/10.1007/s12020-017-1311-8.
Article CAS PubMed Google Scholar
C. Cappelli, I. Pirola, E. Gandossi, A. Cristiano, L. Daffini, B. Agosti et al., Thyroid hormone profile in patients ingesting soft gel capsule or liquid levothyroxine formulations with breakfast. Int. J. Endocrinol. 2016, 9043450 (2016). https://doi.org/10.1155/2016/9043450.
Article CAS PubMed PubMed Central Google Scholar
P. Fallahi, S.M. Ferrari, G. Materazzi, F. Ragusa, I. Ruffilli, A. Patrizio et al., Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): a prospective study. Laryngoscope Investig. Otolaryngol. 3(5), 405–408 (2018). https://doi.org/10.1002/lio2.186.
Article PubMed PubMed Central Google Scholar
P. Colucci, P. D’Angelo, G. Mautone, C. Scarsi, M.P. Ducharme, Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions. Ther. Drug. Monit. 33(3), 355–361 (2011). https://doi.org/10.1097/FTD.0b013e318217b69f.
Article CAS PubMed Google Scholar
M. Tanguay, J. Girard, C. Scarsi, G. Mautone, R. Larouche, Pharmacokinetics and comparative bioavailability of a levothyroxine sodium oral solution and soft capsule. Clin. Pharmacol. Drug. Dev. 8(4), 521–528 (2019). https://doi.org/10.1002/cpdd.608.
Article CAS PubMed Google Scholar
D. Al-Numani, C. Scarsi, M.P. Ducharme, Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions. Int. J. Clin. Pharmacol. Ther. 54(2), 135–143 (2016). https://doi.org/10.5414/CP202485.
Article CAS PubMed Google Scholar
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al., 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020.
Article PubMed PubMed Central Google Scholar
J.R. Garber, R.H. Cobin, H. Gharib, J.V. Hennessey, I. Klein, J.I. Mechanick et al., Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract. 18(6), 988–1028 (2012). https://doi.org/10.4158/EP12280.GL.
S.A. Julious, Sample sizes for clinical trials with normal data. Stat. Med. 23(12), 1921–1986 (2004). https://doi.org/10.1002/sim.1783.
C. Seng Yue, C. Scarsi, E. Bettazzi, G. Mautone, F.S. Celi, M. Ducharme, Proton pump inhibitors do not affect the bioavailability of a novel liquid formulation of levothyroxine. Endocr. Pract. 30(6), 513–520 (2024). https://doi.org/10.1016/j.eprac.2024.03.388.
Article CAS PubMed Google Scholar
M. Ducharme, C. Scarsi, E. Bettazzi, G. Mautone, Y. Lewis, F.S. Celi, A novel levothyroxine solution results in similar bioavailability whether taken 30 or just 15 min before a high-fat high-calorie meal. Thyroid 32(8), 897–904 (2022). https://doi.org/10.1089/thy.2021.0604.
Article CAS PubMed PubMed Central Google Scholar
K. Bornikowska, M. Gietka-Czernel, D. Raczkiewicz, P. Glinicki, W. Zgliczyński, Improvements in quality of life and thyroid parameters in hypothyroid patients on ethanol-free formula of liquid levothyroxine therapy in comparison to tablet LT4 form: an observational study. J. Clin. Med. 10(22), 5233 (2021). https://doi.org/10.3390/jcm10225233.
Comments (0)